Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer
about
A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancermiR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA)Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancermiR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor.Small nucleolar RNA signatures of lung tumor-initiating cellsTumor surveillance by circulating microRNAs: a hypothesis.Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer.miR-429 inhibits migration and invasion of breast cancer cells in vitro.MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndromeExpression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.Selective targeting of alveolar type II respiratory epithelial cells by anti-surfactant protein-C antibody-conjugated lipoplexesExpression profile analysis of microRNAs in prostate cancer by next-generation sequencing.Expression of miR-148/152 family as potential biomarkers in non-small-cell lung cancerMicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal AdenocarcinomaMiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary FibrosismicroRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancerDifferential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) AnalysesSUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancerMicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cellsIdentification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy.Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer.miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value.Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study.Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis.Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma.Evaluation of plasma microRNA levels to predict insensitivity of patients with advanced lung adenocarcinomas to pemetrexed and platinum.Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression.CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway.Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers.Sialyltransferase ST3GAL6 mediates the effect of microRNA-26a on cell growth, migration, and invasion in hepatocellular carcinoma through the protein kinase B/mammalian target of rapamycin pathwaymiR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancermiR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.
P2860
Q26740327-C207D834-8262-41A5-B00F-1552826A9656Q28394161-BAAA45E6-44EE-4303-AD5F-69A041A376A4Q31044667-46E9DE17-9342-4F95-AF2C-6E4D09F33B68Q31139474-8BEB56FD-93AF-45AC-97D4-34716CEA6E98Q33646165-66ECF4D9-58FD-4F64-B917-5430D6081CDDQ34324228-BB677EE4-3755-4D8F-B87F-E16D156EE69FQ34422999-2B6B6D2B-919E-4DDC-8C65-9D44376F4723Q34775801-CDEAA7FA-E10D-4D14-B9EB-26A65A10D876Q35103552-7260C266-45CF-4F4C-80E9-C845F3AB20E0Q35203269-2DBC06CB-BEB8-405E-86C0-438499F70D23Q35434883-BBA9C18D-FB3B-4B5B-938F-C14C39BB95A5Q35544302-36355D94-1840-44C9-B5FB-4C8FB7F96FE3Q35565052-0321C1B9-2F84-458F-979F-BCC0AB3EF418Q35734807-CD686A85-E1C6-4F8F-B97B-E2F029CFBC01Q35852437-995D52B1-66B2-41AE-8D6F-5D9D21019894Q35955237-4BB4BAD9-58E9-4F93-B63A-DB7966C5CDA8Q36059848-A19EF5BC-C785-4B0C-A670-6FC347BC2C6AQ36070655-D9440192-DD79-4A5B-BB23-8B7FA5302F38Q36101421-7B2A1973-0D67-40D0-9E4D-6BD4129DC39AQ36133972-08FFADC2-228C-400D-BA0D-F699B65F372DQ36360734-A87313A0-E593-4117-9FE5-53F2D97C5332Q36544957-750DB8D4-B210-44B3-9A64-4613C1660020Q36839031-E64737DF-7E51-4013-B703-3F3D01CA29B5Q36963041-33459980-CD5E-420B-A2D3-1A24384331BBQ37085896-6AD46368-F09E-40C6-8AB8-BB060ADA05C5Q37121380-F6F1F1F0-EF42-4907-9D68-FBA071397DFDQ37140289-E9609CAA-D8CA-4FBE-9724-8A62B299E5F6Q37392819-6AAC2B5E-6B68-45C2-9E00-1ADEA806F460Q37406674-B7FF7D92-0E83-4560-916B-B8A29F4C4F99Q37581936-9235348C-21EA-47F8-B01C-B17B9980ACE2Q37605063-817CC007-5182-4EB3-ACEE-B3FE584AF627Q37624627-F674B89B-CE74-4714-A469-19207056890AQ37702686-6ED34128-AA4A-4F05-A302-0DB4D3B97D8AQ38449526-A4D869F8-487E-4947-8808-0F5B2760478EQ38710752-652FB612-81F3-415D-89EF-72F9FE819F0EQ38718486-B2946E2F-8824-4202-BC35-E4263D24BF32Q38728098-F2469963-2831-4D37-9891-157554D748BCQ38845695-807E2DE8-C47F-4071-8BDC-A2F6A80B5FB1Q38885118-C5581FE6-166E-4412-9D8F-2511C0C5BDB4Q38911621-A1F9E439-0BAD-4136-A349-461718537040
P2860
Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Downregulation of miR-486-5p c ...... rigenic ARHGAP5 in lung cancer
@en
Downregulation of miR-486-5p c ...... igenic ARHGAP5 in lung cancer.
@nl
type
label
Downregulation of miR-486-5p c ...... rigenic ARHGAP5 in lung cancer
@en
Downregulation of miR-486-5p c ...... igenic ARHGAP5 in lung cancer.
@nl
prefLabel
Downregulation of miR-486-5p c ...... rigenic ARHGAP5 in lung cancer
@en
Downregulation of miR-486-5p c ...... igenic ARHGAP5 in lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Downregulation of miR-486-5p c ...... rigenic ARHGAP5 in lung cancer
@en
P2093
J M Donahue
P2860
P2888
P304
P356
10.1038/ONC.2013.42
P407
P577
2013-03-11T00:00:00Z